Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry

被引:15
|
作者
Proietti, Marco [1 ]
Airaksinen, K. E. Juhani [2 ,3 ]
Rubboli, Andrea [4 ]
Schlitt, Axel [5 ]
Kiviniemi, Tuomas [6 ]
Karjalainen, Pasi P. [7 ]
Lip, Gregory Y. H. [1 ,8 ]
机构
[1] Univ Birmingham, Inst Cardiovas Sci, Birmingham, W Midlands, England
[2] Turku Univ Hosp, Heart Ctr, Turku, Finland
[3] Univ Turku, Turku, Finland
[4] Osped Maggiore Bologna, Div Cardiol, Lab Intervent Cardiol, Bologna, Italy
[5] Martin Luther Univ Halle Wittenberg, Dept Med 3, Halle, Germany
[6] Paracelsus Harz Clin, Dept Cardiol, Bad Suderode, Germany
[7] Satakunta Cent Hosp, Heart Ctr, Pori, Finland
[8] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
关键词
MYOCARDIAL-INFARCTION; ORAL ANTICOAGULATION; CLINICAL-OUTCOMES; TRIPLE THERAPY; MANAGEMENT; STROKE; RISK; CLOPIDOGREL; WARFARIN; DISEASE;
D O I
10.1016/j.ahj.2017.05.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Combination of oral anticoagulation (OAC) and antiplatelets is used in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention and stent (PCI-S) procedure but is associated with increased bleeding when triple antithrombotic therapy (TAT) is used. Our aim was to analyze the impact of time in therapeutic range (TTR) on outcomes, in patients prescribed with TAT. Methods Ancillary analysis from the AFCAS registry in patients assigned to TAT. TTR was calculated with Rosendaal method. Outcomes were analyzed according to TTR tertiles (T1 [<= 56.8%] vs. T2 [56.9-93.8%] vs. T3 [<= 93.9%]). Major bleeding was the primary outcome. Results Of 963 patients enrolled, 470(48.8%) were prescribed with TAT at discharge and qualified for this analysis. Median [IQR] TTR was 80.0% [45.3-100%]. After 359 [341-370] days, major bleeding rates were progressively lower with increasing TTR tertiles (T1 vs. T2 vs. T3: 10.3% vs. 4.7% vs. 2.3%, P = .006). Kaplan-Meier analysis demonstrated a progressively lower risk for major bleeding across tertiles (P = .006). Patients in the highest TTR tertile had a non-significant lower risk for major adverse coronary and cerebrovascular events (MACCE) (log-rank: 4.905, P = .086). Cox regression analysis showed that T2 and T3 were inversely associated with major bleeding (hazard ratio [HR]:0.39, P = .050 and HR: 0.21, P = .005). Continuous TTR was inversely associated with major bleeding (HR: 0.98, P < .001). For MACCE, adjusted Cox analysis found a non-significant lower risk for T3 (HR: 0.64, P = .128). Conclusions In AF patients undergoing PCI-S prescribed TAT, good quality anticoagulation control (as reflected by TTR) was closely related to bleeding outcomes during follow-up. Despite some suggestive trends for an inverse relationship between TTR and MACCE, no definitive conclusions can be drawn, and further large studies are needed.
引用
收藏
页码:86 / 93
页数:8
相关论文
共 50 条
  • [1] Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry
    Proietti, Marco
    Airaksinen, K. E. Juhani
    Rubboli, Andrea
    Schlitt, Axel
    Kiviniemi, Tuomas
    Karjalainen, Pasi P.
    Lip, Gregory Y.
    CIRCULATION, 2016, 134
  • [2] Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry
    Proietti, Marco
    Airaksinen, K. E. Juhani
    Rubboli, Andrea
    Schlitt, Axel
    Kiviniemi, Tuomas
    Karjalainen, Pasi P.
    Lip, Gregory Y.
    CIRCULATION, 2016, 134
  • [3] Octogenarians with atrial fibrillation undergoing percutaneous coronary intervention - the AFCAS registry
    Lahtela, H.
    Bah, A.
    Kiviniemi, T.
    Schlitt, A.
    Rubboli, A.
    Karjalainen, P. P.
    Hartikainen, J. E. K.
    Airaksinen, K. E. J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 677 - 678
  • [4] Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Sutton, Nadia R.
    Seth, Milan
    Ruwende, Cyril
    Gurm, Hitinder S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (09) : 895 - 904
  • [5] Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry
    Lahtela, Heli M.
    Bah, Aissa
    Kiviniemi, Tuomas
    Nammas, Wail
    Schlitt, Axel
    Rubboli, Andrea
    Karjalainen, Pasi P.
    Proietti, Marco
    Hartikainen, Juha E. K.
    Lip, Gregory Y. H.
    Airaksinen, K. E. Juhani
    CLINICAL CARDIOLOGY, 2017, 40 (12) : 1264 - 1270
  • [6] One-Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry
    Rubboli, Andrea
    Schlitt, Axel
    Kiviniemi, Tuomas
    Biancari, Fausto
    Karjalainen, Pasi P.
    Valencia, Jose
    Laine, Mika
    Kirchhof, Paulus
    Niemela, Matti
    Vikman, Saila
    Lip, Gregory Y. H.
    Airaksinen, K. E. Juhani
    CLINICAL CARDIOLOGY, 2014, 37 (06) : 357 - 364
  • [7] Patients with atrial fibrillation undergoing percutaneous coronary intervention
    Dzeshka, Mikhail S.
    Brown, Richard A.
    Lip, Gregory Y. H.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (1-2): : 73 - +
  • [8] Predictive models for adverse clinical outcomes in Chinese patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting
    Zheng, Jian-Yong
    Cao, Yi
    Li, Dong-Tao
    Qiu, Yi-Gang
    Zhao, Li
    Xu, Zheng-Ming
    Huang, Yi-Xiong
    Hong, Zhi-Bo
    Li, Tian-Chang
    Tang, Yi-Da
    Guo, Cheng-Jun
    Ma, Zhi-Min
    Wu, Yong-Quan
    Chen, Yu
    ACTA CARDIOLOGICA, 2022, 77 (04) : 360 - 365
  • [9] The Management of Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention with Stent Implantation: In-Hospital-Data from the Atrial Fibrillation Undergoing Coronary Artery Stenting Study
    Schlitt, Axel
    Rubboli, Andrea
    Lip, Gregory Y. H.
    Lahtela, Heli
    Valencia, Jose
    Karjalainen, Pasi P.
    Weber, Michael
    Laine, Mika
    Kirchhof, Paulus
    Niemela, Matti
    Vikman, Saila
    Buerke, Michael
    Airaksinen, K. E. Juhani
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 82 (07) : E864 - E870
  • [10] Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry
    Puurunen, Marja
    Kiviniemi, Tuomas
    Nammas, Wail
    Schlitt, Axel
    Rubboli, Andrea
    Nyman, Kai
    Karjalainen, Pasi
    Kirchhof, Paulus
    Lip, Gregory Y. H.
    Airaksinen, Juhani K. E.
    BMJ OPEN, 2014, 4 (05):